Life Sciences
Understanding how payers adjudicate a therapy's cost, from the side that has to collect it.
HealthPulse brings provider-side reimbursement experience, drawn from the founder's prior work negotiating directly with payers, to life-sciences organizations navigating coverage-policy design, launch planning, and outcomes-based agreement structures.
Complex-therapy access depends on how coverage policy, billing mechanics, and outcomes-based agreements interact at the state and payer level. HealthPulse's comment to CMS on Cell and Gene Therapy Access Model continuity is a direct example of this analysis applied to a live federal rulemaking.
Discuss a market-access question.
A short conversation is how HealthPulse determines whether the evidence supports further work.
Discuss a Market-Access Question →